• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARTL

ARTL

Artelo Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.46

+0.01 (+0.69%)

Rating:C

Company Profile

CEO

Gregory D. Gorgas

IPO Date

2019-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.40

Prev. Close

$1.45

Day Low

$1.35

Day High

$1.47

52W Low

$1.19

52W High

$85.80

Market Cap

$0.00B

Volume

0.26M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
2 Feb 2026MATSUI CONNIEdirectorA-AwardAcquired292$1.71
2 Feb 2026Blayney DouglasdirectorA-AwardAcquired
292
$1.71
2 Feb 2026EMANUELE ROBERT MARTINdirectorA-AwardAcquired292$1.71
2 Feb 2026Kelly StevendirectorA-AwardAcquired292$1.71
2 Feb 2026FAVORITO TAMARA AdirectorA-AwardAcquired292$1.71
2 Feb 2026Reyes GregorydirectorA-AwardAcquired292$1.71
2 Feb 2026Spring Mark EdwardChief Financial OfficerA-AwardAcquired36,391$1.68
2 Feb 2026Gorgas Gregory D.director, officer: Pres, CEO, CFO, Treas & SecrA-AwardAcquired154,713$1.68
17 Nov 2025Spring Mark EdwardChief Financial OfficerDisposed2,500$11.03
30 Oct 2025MATSUI CONNIEdirectorC-ConversionDisposed0$0.00